Updated on 3 October 2013
Singapore General Hospital's mobile application, SGH Diabetes Pal, will help patients overcome the problem of insulin dosage
Singapore: Many patients with type 2 diabetes who are new to insulin therapy face the daily challenge of not knowing how much insulin to inject at the appropriate time. Part of the reason is the lack of confidence to self-adjust insulin dosage without doctor's supervision. Delayed dosage adjustment may result in the persistence of high sugar levels that could lead to serious diabetic complications.
Doctors from the Singapore General Hospital (SGH) Department of Endocrinology and Integrated Health Information Systems (IHiS) have developed a mobile application named SGH Diabetes Pal to help patients overcome the problem. This app takes the guesswork out of insulin injections by informing users of the required dosage based on the fasting blood sugar reading they input into the app every morning.
To study if the app can help patients achieve good glycaemic control, SGH and Duke-NUS Graduate Medical School are conducting a study to determine its effectiveness. This is the first such clinical trial involving mobile apps in a hospital setting.
"As part of the Academic Healthcare Cluster, we are always looking at innovative ways to improve patient empowerment and clinical outcomes. The SGH Diabetes Pal is an example of how we leverage on technology to achieve that goal," said Dr Bee Yong Mong, Director, Diabetes Centre and Consultant, Department of Endocrinology, SGH.
"This study can potentially change current practices and improve the clinical understanding of diabetes management given the pervasiveness and simplicity of mobile apps," said Dr. Bee, alo the site-Principal Investigator of the study.